Bio-Techne (TECH) Misses Q4 EPS by 4c

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $0.92, $0.04 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $134.8 million versus the consensus estimate of $129.23 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c